Panelists
*Bob Temple, FDA  *Gregory Campbell, U.S. Food and Drug Administration  *Greg Soon, FDA  *Jon Norton, FDA  *Mohammad Huque, FDA  *Thomas Fleming, University of Washington  *Steven Snapinn, Amgen/GBE 

Keywords: